Atlas Trials

Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults

Clinical trial NCT02718469 · COMPLETED

Trial details

NCT number
NCT02718469
Sponsor
Auro Vaccines LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ebola Virus Disease
Start date
2015-12-22
Primary completion
2016-09-15
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.